Hughes to intro bill allowing experienced teachers to return to classrooms

first_img22Jan Hughes to intro bill allowing experienced teachers to return to classrooms Categories: Hughes News Legislation removes sunset on 2012 lawState Rep. Holly Hughes, R-Montague, will introduce legislation next week that would eliminate the sunset provision on Public Act 464 of 2012, permitting retired teachers and school employees to re-enter the work force to fill critical, specialized vacancies in Michigan schools.“Our children’s education is paramount in any day and age,” Hughes said. “Especially in situations where our communities don’t have enough educators to go around, we simply must allow qualified, experienced teachers to return to the work force so our children have better opportunities to learn and succeed in school.”House Bill 4059 eliminates the July 1, 2014, sunset that was in Hughes’ original 2012 legislation, giving the state school superintendent the ability to determine critical teacher shortages in districts across Michigan and filling the vacancies with qualified personnel. In many situations, the shortages are in crucial positions that require educators with particular training, such as speech pathologists and special education staff.Hughes met with Muskegon County superintendents last week, where this issue was once again raised. The superintendents expressed interest in the legislation’s introduction, as they said varying departments still experience shortages of qualified teachers.Muskegon Intermediate School District (ISD) Superintendent John Severson praised Hughes’ work on the issue.“As an ISD superintendent, I recognize the importance of this legislation, for the fact that there are positions that we cannot fill and that are vitally important to the delivery of services for our students,” Severson said. “Furthermore, schools that hire such staff will be required to pay for both retirement and pension benefits, therefore, causing no harm to the retirement system.”Hughes legislation retains the existing law’s safeguard that prevents educators from earning full pay while still receiving their retirement pension to eliminate fraudulent “double dipping.”“Michigan students deserve to receive the best education we can give them,” Hughes said. “These vacancy situations are ones we can easily remedy, so let’s get these teachers and staff back into the classrooms with our children.”last_img read more

German technology firm WISI will use ANGA COM to s

first_imgGerman technology firm WISI will use ANGA COM to showcase new headend solutions for content providers and operators.WISI will showcase optimised headend solutions for content providers and operators of next generation networks. This includes the debut the Inca ABR Transcoder 3840 along with new features for Tangram and Chameleon.The new Inca ABR Transcoder 3840 is optimised for multiscreen & OTT applications and can transcode up to 24 HD or 48 SD channels to multi-bitrate profiles. Thanks to its high density, a large number of TV channels can be processed in a single rack unit for OTT delivery, according to WISI. In addition, the company says it has improved the flexibility and security of investment significantly for the operator.The high density is maintained even when source codecs, bitrates or formats are changed by the content owner, which helps operators plan OTT projects with confidence – e.g. from MPEG-2 to MPEG-4, from 1080i with 30fps to 720p with 60fps or from SPTS to MPTS, according to WISI. Finally, the ABR Transcoder 3840 features low energy consumption and low operational costs, the company says.WISI has integrated its multi-headend platform, Chameleon into the globally-deployed All Seeing Eye (ASE) monitoring and troubleshooting tool. This multi-view monitoring platform features a visual mosaic of video thumbnails and gives operators greater visibility and reliability within their network, according to WISI.The faster detection and troubleshooting of errors in the transmitting of TV channels and streams allows to the operator to reduce outages significantly and increase customer satisfaction while also lowering operational costs.Additionally, WISI says it has optimised the encoding capabilities of Chameleon. Thanks to higher density, the costs for encryption per TV channel have decreased significantly, according to the company, something that is important for network operators and content providers supplying TV channels and video streams to the hospitality industry that need to protect and encode content.Chameleon now supports the new standard for broadcasting via satellite (DVB-S2X) and offers additional features such as traffic shaping and real-time transport stream monitoring.WISI has also integrated support for the visual monitoring platform, All Seeing Eye into its high-density platform Tangram. Tangram operators now profit from more efficient channel encoding options provided by new software licenses for Pro:Idiom and Samsung Lynk, according to WISI. Finally, Tangram now supports the satellite broadcasting standard DVB-S2x.WISI will exhibit at ANGA COM on stand 8.R11last_img read more

Interdisciplinary medication education improves patient outcomes reduces hospital readmissions

first_img After a patient is admitted, an assigned bedside nurse reviews any new medications with the patient, family member, or caregiver, including what they are used for and any side effects of that particular medication. “This can be easily done through patient medication cards that are premade and ready to go,” See said. Once the discharge medications have been prescribed by the physician, the cardiology nurse navigator asks the patient to write out medication information on a visual aid form called a medication log. This include the names of their discharge medications, what the medications are used for, dose, frequency and what time of day the medications should be taken. See said, “This can be done in conjunction with the floor pharmacist’s instructions at discharge or done separately depending on similar availability.” Next, the floor pharmacist educates the patient in greater depth about their medications, explaining potential side effects and any drug interactions, what to do if a dose is missed and offering any other needed instructions. After discharge, the patient will receive a transition of care phone call within 48 hours from a care coordinator or the nurse navigator. This call includes medication teach back, which requires the patient to read back from memory or read from their prescription bottles the name and usage of their medication. At the patient’s first outpatient cardiac rehab appointment, they are asked to place a check mark by their current medications from a list of common cardiac medications. This helps ensure they are knowledgeable about their medications. Reviewed by James Ives, M.Psych. (Editor)Mar 14 2019Patients understanding their medications and taking them as instructed are important parts of improving the care and outcomes of heart attack patients, as well as potentially reducing avoidable readmissions, according to research presented at the ACC Quality Summit in New Orleans.A heart attack is typically an unexpected event, which can leave patients overwhelmed by new medications, clinicians and other additions to their health care upon release from the hospital. When patients are discharged from the hospital, hospital staff educate them about their medications. However, many patients have difficulty understanding and following these instructions.A new quality improvement plan, developed at Olathe Medical Center in Olathe, Kansas, and initiated as part of the American College of Cardiology’s Patient Navigator Program: Focus MI, showed promising results and shed light on how to approach the issue. The study group considered the patient perspective on the hospital discharge and follow-up experience when developing solutions.”When patients leave a hospital, they often feel there has been little preparation for the discharge plan of care,” said Tara See, RN, BSN, Olathe Medical Center and a leader in the initiative. “Another complaint is that follow-up care is not well established at discharge, there is limited communication with providers receiving them after hospitalization, medication reconciliation and instructions may be hard to understand, and expectations are unclear regarding their recovery and needs when they are discharged.”In April 2018, an interdisciplinary team at Olathe Medical Center, including an assigned bedside RN, cardiology nurse navigator, floor pharmacists and outpatient cardiac rehab staff, established and implemented the following medication education communication process: Related StoriesChildren’s Colorado granted IAC’s Cardiovascular Catheterization accreditationStudy: Two-thirds of pneumonia patients receive more antibiotics than they probably needHome-based support network helps stroke patients adjust after hospital dischargeUsing the Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) survey–a satisfaction survey required by the Centers for Medicare and Medicaid Services for all U.S. hospitals, the study group found the hospital’s HCAHPS scores for medication understanding increased by 10 percent between quarter one and quarter two in 2018 following program implementation. Additionally, before plan implementation, the 2018 quarter one unadjusted readmission rate was 8.2 percent. Since implementation, the quarter two rate went down to 3.4 percent and quarter three was 3.6 percent.”We realize improving medication understanding is only part of what hospitals need to do to help reduce readmissions,” See said. “We are also continuing to focus on other goals, such as increasing risk assessment and appropriate interventions placed on high risk patients. We believe this will optimize our process and further decrease readmissions.”Source: read more

Researchers study reason for burden of HLBS disorders in south rural communities

first_imgReviewed by James Ives, M.Psych. (Editor)May 23 2019People born in rural communities in the South, especially in southern Appalachia and the Mississippi Delta, may live shorter and less healthy lives than their counterparts elsewhere in the country, in part due to a high burden of heart, lung, blood and sleep disorders (HLBS). Within the same Southern regions, however, there are counties with very low risk of disease that have profiles of economic disadvantages, race/ethnicity, and rurality similar to those considered high risk.In an effort to understand why certain factors amplify risk in some rural counties and what renders some communities more resilient, researchers will be studying 4,000 multi-ethnic participants from 10 of the low-income rural counties in Kentucky, Alabama, Mississippi and Louisiana recruited into a new longitudinal cohort study. The Risk Underlying Rural Areas Longitudinal Study (RURAL) will allow researchers to learn what causes the burden of HLBS disorders in these communities and how to alleviate them.This multi-site prospective cohort study will be coordinated by Boston University School of Medicine’s Vasan Ramachandran, MD, FAHA, FACC, principal investigator and Boston University director of the renowned Framingham Heart Study, with which he has been affiliated for more than 20 years. Over fifty investigators at 16 institutions will participate in this six-year, $21.4 million study funded by the National Heart, Lung, and Blood Institute, part of the National Institutes of Health.Using a self-contained mobile examination unit, ‘a research center on wheels,’ a transdisciplinary team will conduct an approximately four-hour detailed baseline examination on the study participants. Familial, lifestyle and behavioral factors, along with medical history including risk for HLBS disorders will be recorded. Environmental and economic factors also will be studied and standard and novel risk factors for HLBS disorders will be assayed. Investigators will use smart phones and wearable activity monitors in order to help collect health and lifestyle information of the participants. The rural health challenge in the South does not spare any race or ethnicity. These high risk and economically disadvantaged rural communities are vulnerable to clusters of multiple health problems. We aim to understand the rural health challenges in the South and share our findings with and offer health education to these rural communities.”Vasan Ramachandran, Boston University School of Medicine Stephanie Boone, PhD, MPH, University of Louisville (Kentucky); Stephanie Broyles, PhD, LSU’s Pennington Biomedical Research Center; Ervin Fox, MD, MPH, University of Mississippi Medical Center; Suzanne Judd, PhD, University of Alabama at Birmingham and Paul Targonski, MD, PhD, University of Virginia at Charlottesville will play a central role in participant recruitment, retention, follow-up, data collection, return of results, community engagement and education.Source: Boston University School of Medicinelast_img read more

Research findings lead to new clinical trial for people with myelofibrosis

first_imgRelated StoriesOlympus launches next-generation X Line objectives for clinical, research applicationsScientists develop universal FACS-based approach to heterogenous cell sorting, propelling organoid researchOlympus Europe and Cytosurge join hands to accelerate drug development, single cell researchThe researchers worked to establish whether blocking the nuclear cytoplasmic transport process would slow the growth of myelofibrosis cells. To accomplish this, they generated a type of mouse with a specific mutation that leads to symptoms very similar to those experienced by myelofibrosis patients. When these mice were treated with the newly tested drug selinexor they responded just as well as those treated with ruxolitinib, and importantly, selinexor actually appeared to reduce the percentage of malignant cells.Based on these findings, the researchers designed a new clinical trial to study the effectiveness of selinexor in people with myelofibrosis. The clinical trial of selinexor in the treatment of relapsed/refractory myelofibrosis is now open at HCI. The researchers aim to enroll at least 24 patients who will receive the treatment in a setting that will allow for rigorous examination of any clinical benefit and monitoring of side effects. If this early trial indicates positive outcomes for patients, more extensive studies involving additional sites and more patients will be planned. Our results opened a new window for therapeutic intervention. By wonderful coincidence, selinexor, an inhibitor of this specific mechanism, is in clinical trials for certain blood cancers and now will be tested specifically in myelofibrosis patients.” Reviewed by James Ives, M.Psych. (Editor)Jun 20 2019Researchers at Huntsman Cancer Institute (HCI) at the University of Utah (U of U) discovered in laboratory studies that an experimental drug called selinexor may block a crucial survival pathway exploited by myelofibrosis cells. Their study was published in Clinical Cancer Research, a journal of the American Association of Cancer Research. Based on these findings, they designed a clinical trial now open at HCI to examine this drug’s effectiveness in patients with myelofibrosis (National Clinical Trial 03627403)Myelofibrosis is a rare cancer that prevents the bone marrow from making healthy blood cells. Life expectancy varies, but most patients will not live beyond five years after the diagnosis. HCI treats about 25 newly diagnosed myelofibrosis patients a year.Srinivas Tantravahi, MBBS, MRCP, a physician-scientist at HCI and assistant professor of medicine at the U of U, takes care of patients with myelofibrosis, and says it is a very debilitating disease. “Essentially, it’s a bone marrow failure. The patient will experience severe symptoms including enlargement of the spleen, anemia, pain in the belly, fatigue, and a very poor quality of life,” says Tantravahi, who was part of the study team. “A stem cell transplant can potentially cure the disease, but most patients diagnosed with myelofibrosis are older or not healthy enough to undergo the weeks-long procedure.”A drug called ruxolitinib is the current primary treatment for myelofibrosis patients who are not healthy enough to receive a stem cell transplant. This drug can decrease spleen size, improve symptoms and improve quality of life, but it does not typically reduce the percentage of malignant cells. The lack of available therapies for myelofibrosis patients motivated the research team at HCI to look for new avenues for treatment. “Ruxolitinib is a fine drug, but its effects are mostly short-lived. And, until now, there were no other options for patients who aren’t healthy enough for a stem cell transplant,” said Dongqing Yan, PhD, a research associate in the Deininger/O’Hare Lab at HCI and lead author on the study.The team discovered myelofibrosis cells are highly sensitive to blockade a cellular process called nuclear-cytoplasmic transport.Anthony Pomicter, MS, manager of the Deininger/O’Hare lab explains: Source:Huntsman Cancer Institute The ability to advance a study like this from bench to bedside – from first discovery in a laboratory setting to first in the world clinical trial – is a credit to the unique environment at HCI. Myelofibrosis is a rare cancer, and it makes life miserable for those affected. It is extremely important that HCI and other institutions continue to push the discovery effort in all types of cancer, including rare diseases like myelofibrosis, so can we bring better treatment options to our patients.”Michael Deininger, MD, PhD, HCI senior director of transdisciplinary research and professor of medicine at the U of U, and senior author on the studylast_img read more

Coming to store shelves cameras that guess your age and sex

first_img Microsoft follows Amazon in pursuit of cashier-less stores This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only. Walgreens, which has more than 8,000 drugstores, installed cooler doors with cameras and sensors at six locations in Chicago, New York, San Francisco and Bellevue, Washington. Instead of the usual clear glass doors that allow customers to see inside, there are video screens that display ads along with the cooler’s contents. This March 7, 2019, photo shows a smart shelf area at Walgreen’s in Chicago. Walgreens, which has more than 8,000 drugstores, installed cooler doors with cameras and sensors at six locations in Chicago, New York, San Francisco and Bellevue, Washington. Instead of the usual clear glass doors that allow customers to see inside, there are video screens that display ads along with the cooler’s contents. (AP Photo/Teresa Crawford) This March 7, 2019, photo shows a smart shelf area at Walgreen’s in Chicago. Walgreens, which has more than 8,000 drugstores, installed cooler doors with cameras and sensors at six locations in Chicago, New York, San Francisco and Bellevue, Washington. Instead of the usual clear glass doors that allow customers to see inside, there are video screens that display ads along with the cooler’s contents. (AP Photo/Teresa Crawford) © 2019 The Associated Press. All rights reserved. Citation: Coming to store shelves: cameras that guess your age and sex (2019, April 23) retrieved 17 July 2019 from Above the door handle is a camera that can try to guess ages and track irises to see where you are looking, but Walgreens said those functions are off for now. The company said the cameras are currently being used to sense when someone is in front of the cooler and count the number of shoppers passing by. It declined to say if it will turn on the other functions of the camera.”All such enhancements will be carefully reviewed and considered in light of any consumer privacy concerns,” Walgreens said.Advocates of the technology say it could benefit shoppers by showing them discounts tailored to them or drawing attention to products that are on sale. But privacy experts warn that even if the information being collected is anonymous, it can still be used in an intrusive way.For instance, if many people are eyeing a not-so-healthy dessert but not buying it, a store could place it at the checkout line so you see it again and “maybe your willpower breaks down,” said Ryan Calo, a professor at the University of Washington School of Law and co-director of its Tech Policy Lab.”Just because a company doesn’t know exactly who you are doesn’t mean they can’t do things that will harm you,” Calo said.The technology could also lead to discriminatory practices, like raising prices when an older person walks in or pushing products based on your perceived mood such as ads for anti-depression medication if the cameras think you look sad, adds Dixon of the World Privacy Forum. .”We shouldn’t be gathering the emotional state of anyone,” Dixon said.At a Walgreens in New York, a sign above a rack of wines said the store is testing cameras and sensors that “do not identify you or store any images.” The sign doesn’t say where the cameras or sensors are, but it does have a web address for the privacy policy of Cooler Screens, the company that makes the doors.Calvin Johnson, who was looking for a Snapple, said he visited the store before, but didn’t notice the cameras until a reporter pointed them out. Explore further “I don’t like that at all,” Johnson said.Another shopper, Ray Ewan, said he noticed the lenses while grabbing a Diet Coke, but isn’t concerned since cameras are hard to avoid.”There’s one on each corner,” Ewan said.Not all retailers are keen on adding embedded cameras. Walmart’s Sam’s Club, which is testing shelves with digital price tags, is cautious about them.”I think the most important thing you do with tech like that is to make sure people know,” said John Furner, Sam’s Club’s CEO. “You don’t want to surprise people on how you use technology or data.”Jon Reily, vice president of commerce strategy at consultancy Publicis.Sapient, said retailers risk offending customers who may be shown ads that are aimed at a different gender or age group. Nonetheless, he expects the embedded cameras to be widely used in the next four years as the technology gets more accurate, costs less and shoppers become used to it.For now, he said, “we are still on the creepy side of the scale.” Eyeing that can of soda in the supermarket cooler? Or maybe you’re craving a pint of ice cream? A camera could be watching you. This March 7, 2019, photo shows a smart shelf area at Walgreen’s in Chicago. Walgreens, which has more than 8,000 drugstores, installed cooler doors with cameras and sensors at six locations in Chicago, New York, San Francisco and Bellevue, Washington. Instead of the usual clear glass doors that allow customers to see inside, there are video screens that display ads along with the cooler’s contents. (AP Photo/Teresa Crawford) But it’s not there to see if you’re stealing. These cameras want to get to know you and what you’re buying.It’s a new technology being trotted out to retailers, where cameras try to guess your age, gender or mood as you walk by. The intent is to use the information to show you targeted real-time ads on in-store video screens.Companies are pitching retailers to bring the technology into their physical stores as a way to better compete with online rivals like Amazon that are already armed with troves of information on their customers and their buying habits.With store cameras, you may not even realize you are being watched unless you happen to notice the penny-sized lenses. And that has raised concerns over privacy.”The creepy factor here is definitely a 10 out of 10,” said Pam Dixon, the executive director of the World Privacy Forum, a nonprofit that researches privacy issues.At the National Retail Federation trade show in New York earlier this year, a smart shelf on display by Mood Media tried to detect “happiness” or “fear” as people stood in front it—information a store could use to gauge reaction to a product on the shelf or an ad on a screen. Cineplex Digital Media showed off video screens that can be placed in malls or bus stops and try to tell if someone is wearing glasses or sporting a beard, which in turn can be used to sell ads for new frames or razors.The screens can also be placed at the drive-thru. A minivan pulling into a fast food restaurant, for example, might get an ad for a family-sized meal on the video screen menu.For now, the cameras are in just a handful of stores.Kroger, which has 2,800 supermarkets, is testing cameras embedded in a price sign above shelves in two stores in the suburbs outside Cincinnati and Seattle. Video screens attached to the shelves can play ads and show discounts. Kroger said the cameras guess a shopper’s age and sex but the information is anonymous and the data is not being stored. If the tests work out well, the company said it could expand it into other locations.last_img read more